Mandate

Vinge advises Expedition Growth Capital in connection with Storykit’s USD 10 million investment round

Vinge advises Expedition Growth Capital in connection with Storykit’s investment round of USD 10 million led by Expedition Growth Capital. The investment in Storykit is Expedition Growth Capital’s first investment in the Nordics.

Serving large and medium sized enterprises, Storykit is leveraging artificial intelligence enabling its users to create video and tell stories on social platforms, and has quickly grown to become the leading video creator in the Nordics as well as recently expanded into several European markets. With the new funding, they will accelerate innovation and expansion at an even higher pace.

Expedition Growth Capital is a USD 200+ million London-based growth equity fund, focused solely on investing in fast growing and capital efficient B2B software companies in Europe and Israel, and this is Expedition Growth Capital’s first investment in the Nordics.

Vinge’s team consisted of Karl Klackenberg, Johan Larsson, Milad Kamali and Nina Gransäter (M&A), Stojan Arnerstål (IPR), Lisa Hörnqvist (Commercial Agreements) and Veronika Garemark (Employment).

 

Related

Vinge advised Dr Schär

Vinge advised Dr Schär in the acquisition of Semper AB:s glutenfree business Dr. Schär, an Italian based company, is a developer of product for special nutritional needs.
February 29, 2024

Vinge advises Irisity AB in connection with the acquisition of Ultinous and a directed share issue

Vinge advises Irisity AB in connection with the acquisition of Ultinous and a directed share issue
February 29, 2024

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with SBB establishing a joint venture company for community properties together with Castlelake, LP ("Castlelake").

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with SBB establishing a joint venture company for community properties together with Castlelake, LP ("Castlelake").
February 29, 2024